Even though the global consumer health market remains highly fragmented two of the largest players say they don’t expect to strike any transformational deals any time soon.
Transformational M&A Not On Horizon For Haleon Or Bayer
Haleon CEO Brian McNamara and Bayer Consumer Health president Julio Triana independently tell the Barclays Consumer Conference that their respective firms are unlikely to secure any transformational mergers or acquisitions in the medium term. Both companies are prioritizing bolt-on acquisitions for the next few years.
More from Strategy
A round-up of the latest European consumer health appointments: Maxwellia adds CFO and board member; Reckitt restructures operations; Barentz names CEO.
A round-up of the latest European consumer health industry appointments: Boiron hires former Henkel exec as CEO; Dr. Theiss Naturwaren names managing director; ProBiotix Health adds scientific expertise.
Round-up of the latest people moves: CHP Australia names new chief exec; Opella appoints Vietnam head; Ascendis makes permanent CFO appointment.
A round-up of the latest European consumer health industry appointments: Haleon adds to board; Stada names investor relations head; Aker BioMarine hires marketing expert.
More from Business
Hiya has more than 200,000 customers in the direct-to-consumer channel, all using subscriptions ordered on the brand’s website, and plans to expand into online marketplaces and retail chains. The startup “offers a compelling subscription model with attractive margins, profitability, and strong cash flow generation,” says USANA CEO Jim Brown.
A round-up of the latest European consumer health industry appointments: Boiron hires former Henkel exec as CEO; Dr. Theiss Naturwaren names managing director; ProBiotix Health adds scientific expertise.
Petition by Leprino Nutrition could help manufacturers trim production spending as costs increase throughout the supply chain leading to higher product prices even as the global whey protein ingredient market reached nearly $9bn in 2023 and is projected to reach nearly $23bn in 2032.